AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Neuronal Monoclonal Antibodies (NeuroMabs)

Technology Application: These NeuroMabs can be used to recognize endogenous target proteins in tissue and recombinant proteins with established links to disease states.

Detailed Technology Description: In addition to the high quality monoclonal antibodies available for purchase at the UC Davis/NIH Neuromab Facility, many NeuroMab hybridomas are available for non-exclusive licensing. Please see the Neuromab Catalog (see www.neuromab.ucdavis.edu) for NeuroMabs and datasheets. Additional NeuroMabs are added as they become available. (Note: not all NeuroMabs present in the NeuroMab Catalog may be available for licensing from UC.)

Others

Related Materials

The UC Davis NINDS/NIMH NeuroMab Hybridoma Facility
UC Davis/NIH NeuroMab Facility

Related Technologies

Anti-MMP9, Anti-Menke's Disease, and Anti-Wilson's Disease mAbs

Additional Technologies by these Inventors

Tech ID/UC Case

11194/2006-468-0

Related Cases

2006-468-0

*Abstract: Monoclonal Antibodies Against Molecular Targets Found in the Nervous System

*Principal Investigator: Name: James Trimmer
Department:

Country/Region: USA

For more information, please click Here